InMode to Report Third Quarter 2026 Financial Results on November 11, 2026, Expects Third Quarter Revenue of $91.8 Million to $92.0 Million, Reiterates FY 2026 Revenue Guidance Between $365M-$375M PR Newswire Tue, October 13, 2026 at 7:00 AM EDT 3 min read INMD +0.63% ^IXIC -0.44% Trade InMode on Coinbase Trading disclosure Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
YOKNEAM, Israel, Oct. 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the third quarter of 2026 before the Nasdaq market opens on Wednesday, November 11, 2026.
InMode is currently finalizing its financial results for the third quarter of 2026. While complete financial information and operating data are not yet available, set forth below are certain preliminary results for such period, which are unaudited and subject to the completion of InMode's quarter-end closing procedures, final adjustments and other developments that may arise between now and the time such financial results are finalized. Based on these preliminary results, management expects:
Revenue for the third quarter of 2026 to be in the range of $91.8 million to $92.0 million
Full year 2026 revenue to be in the range of $365 million to $375 million, consistent with prior guidance
As the Company's Special Committee continues its evaluation of a strategic proposal, InMode will not host an investor conference call or webcast in connection with its third quarter 2026 earnings release and will not conduct investor meetings at this time.
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.
The information in this press release includes forward-looking statements within the meaning of the federal securities laws, including statements regarding InMode's preliminary financial results for the third quarter of 2026 and the timing of the release of its final results. These statements generally relate to future events or InMode's future financial or operating performance. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern InMode's expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. InMode's preliminary results are subject to the completion of its financial closing procedures and may differ from the final results. Consequently, actual results could differ materially from those expressed or indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and its subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after the date of this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.
Company Contact:Moshik ItzkovichChief Financial OfficerEmail: Moshik.Itzkovich@inmodemd.com
Investor Relations Contact:Miri SegalMS-IR LLCEmail: ir@inmodemd.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-to-report-third-quarter-2026-financial-results-on-november-11--2026--expects-third-quarter-revenue-of-91-8-million-to-92-0-million-reiterates-fy-2026-revenue-guidance-between-365m-375m-302906038.html
